| Literature DB >> 36000062 |
Keisuke Iritani1, Masanori Teshima1, Hikari Shimoda1, Hirotaka Shinomiya1, Naoki Otsuki1, Ken-Ichi Nibu1.
Abstract
Objective: We investigated the factors affecting postoperative parathyroid gland (PTG) function and devised an objective index to predict the postoperative PTG function during total thyroidectomy. Method: This was a retrospective clinical review of 21 consecutive patients who were diagnosed with papillary thyroid carcinoma and underwent total thyroidectomy. The maximum intensity ratio (MIR) was determined as the maximum fluorescence intensity after ICG injection divided by the intensity before ICG injection.Entities:
Keywords: autofluorescence; indocyanine green; near‐infrared; parathyroid gland; thyroidectomy
Year: 2022 PMID: 36000062 PMCID: PMC9392388 DOI: 10.1002/lio2.868
Source DB: PubMed Journal: Laryngoscope Investig Otolaryngol ISSN: 2378-8038
FIGURE 1A PDE‐neo image and analysis of fluorescence. Intraoperative photograph of the preserved parathyroid glands with PDE system under white light (A), under infrared observation before ICG injection (B), and after ICG injection (C). Red arrows show the preserved right upper parathyroid gland, and yellow arrows show the left upper parathyroid gland. A screenshot of the fluorescence intensity analysis is shown in (D). Screenshot of the analysis in ROIs. The right upper gland, surrounded by a red frame, shows an increase in luminance after ICG injection. In contrast, the left upper gland surrounded by a yellow frame showed a poor increase in brightness, even after ICG injection.
Baseline characteristics of the study population by postoperative parathyroid hormone status
| Factors | Postoperative hypoparathyroidism |
| |
|---|---|---|---|
| + ( | − ( | ||
| Age | |||
| <55 | 5 | 3 | >.99 |
| ≧55 | 8 | 5 | |
| Gender | |||
| Male | 8 | 4 | .673 |
| Female | 5 | 4 | |
| Body mass index (kg/m2) | |||
| <30 | 12 | 6 | .531 |
| ≧30 | 1 | 2 | |
| pT | |||
| T0‐2 | 5 | 4 | .827 |
| T3 | 7 | 3 | |
| T4 | 1 | 1 | |
| Lateral neck dissection | |||
| None | 3 | 6 |
|
| unilateral/bilateral | 10 | 2 | |
| In situ preservation of PGs | |||
| Two PGs | 4 | 3 | >.99 |
| One PG | 9 | 5 | |
| Auto‐transplanted PGs | |||
| Two PGs | 6 | 2 | .535 |
| One PG | 3 | 4 | |
| No PG | 4 | 2 | |
| Device for near‐infrared fluorescence imaging | |||
| PDE‐neo | 9 | 5 | >.99 |
| VISERA‐ELITE II | 4 | 3 | |
Abbreviations: +, intact PTH concentration less than 15 pg/ml on POD1; −, intact PTH concentration 15 pg/ml or more on POD1.
Individual clinical/pathological outcomes and surgical findings (n = 21)
| No. | age | gender | BMI | pT | pN | LND | No. of auto‐transplanted PG(s) | No. of excised PG(s) | in‐situ preserved PG(s) | Intensity ratio | Maximum intensity ratio | iPTH (POD1) | iPTH (3 M) | device |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 82 | M | 24 | 1b | 0 | — | 1 | 0 | LS | LS: 6.59 | 6.59 | 20 | — | VISERA ELITEII |
| 2 | 51 | M | 32 | 3 | 1a | — | 0 | 1 | RS, RI | RS: 1.20 RI: 2.14 | 2.14 | 34 | — | PDE‐neo |
| 3 | 55 | M | 32 | 3 | 1b | bil | 1 | 1 | RS | RS: 1.34 | 1.34 | 4 | 17 | VISERA ELITEII |
| 4 | 81 | M | 19 | 3 | 1a | — | 1 | 0 | LS | LS: 2.29 | 2.29 | 29 | 40 | VISERA ELITEII |
| 5 | 71 | M | 25 | 3b | 1b | R | 0 | 0 | LS | LS: 1.49 | 1.49 | 6 | 4 | VISERA ELITEII |
| 6 | 39 | M | 29 | 2 | 1b | R | 0 | 0 | LS | LS: 3.31 | 3.31 | 27 | — | VISERA ELITEII |
| 7 | 53 | M | 25 | 3 | 1b | R | 2 | 0 | LS | LS: 1.19 | 1.19 | 4 | 13 | VISERA ELITEII |
| 8 | 69 | F | 29 | 3a | 1b | bil | 0 | 3 | LS | LS: 1.36 | 1.36 | 3 | 3 | VISERA ELITEII |
| 9 | 55 | F | 30 | 1b | 1b | L | 2 | 0 | RS, LS | RS: 1.34, LS: 1.67 | 1.67 | 4 | 24 | PDE‐neo |
| 10 | 71 | F | 21 | 2 | 1b | bil | 2 | 1 | LS | LS: 1.538 | 1.538 | 2 | 6 | PDE‐neo |
| 11 | 77 | F | 26 | 3b | 1a | — | 2 | 1 | LS | LS: 3.72 | 3.72 | 19 | — | PDE‐neo |
| 12 | 64 | F | 23 | 4a | 0 | — | 2 | 1 | LS | LS: 2.90 | 2.90 | 17 | — | PDE‐neo |
| 13 | 75 | M | 15 | 3 | 0 | — | 2 | 1 | LS | LS: 5 | 5.00 | 12 | 19 | PDE‐neo |
| 14 | 54 | M | 25 | 2 | 1a | — | 1 | 0 | RS, LS | RS: 2.32, LS: 1.90 | 2.32 | 13 | 31 | PDE‐neo |
| 15 | 58 | F | 34 | 1b | 0 | — | 1 | 0 | RS, LS | RS: 3.93, LS: 1.90 | 3.93 | 26 | — | PDE‐neo |
| 16 | 61 | M | 28 | 2 | 1a | L | 2 | 1 | RS | RS: 1.61 | 1.61 | 6 | 19 | PDE‐neo |
| 17 | 61 | F | 29 | 3 | 1b | L | 1 | 2 | RS, LS | RS: 2.24, LS: 2.17 | 2.24 | 13 | 49 | PDE‐neo |
| 18 | 44 | F | 23 | 4a | 1b | R | 0 | 1 | LS | LS: 1.57 | 1.57 | 2 | 20 | PDE‐neo |
| 19 | 29 | F | 25 | 1 | 1b | R | 1 | 2 | RS, LS | RS: 2.33 LS: 1.71 | 2.33 | 25 | — | PDE‐neo |
| 20 | 53 | M | 27 | 3b | 1a | R | 0 | 0 | LS | LS: 1.80 | 1.80 | 2 | 5 | PDE‐neo |
| 21 | 42 | M | 30 | 2 | 1b | — | 2 | 0 | RS, LS | RS: 1.69, LS: 1.36 | 1.69 | 4 | 22 | PDE‐neo |
Abbreviations: BMI, body mass index; F, female; iPTH (3 M), intact PTH 3 months after the surgery; iPTH (POD1), intact PTH on the first postoperative day; LND, lateral neck dissection; LS, left superior gland; M, male; PGs, parathyroid glands; RI, right inferior gland; RS, right superior gland.
FIGURE 2Correlation between Maximum Intensity Ratio and intact PTH. MIR, maximum intensity ratio; iPTH, intact PTH; POD1, the first postoperative day
FIGURE 3ROC of MIR cutoff value to predict postoperative parathyroid function. The ROC curve analysis demonstrates that the optimal MIR cutoff value is 2.14. The sensitivity was 0.769 and the specificity was 1.00.